• Canagliflozin Hemihydrate: SGLT2 Research Guide

  2026-08-16

  Canagliflozin hemihydrate is a high-purity small-molecule SGLT2 inhibitor for glucose metabolism research and diabetes mellitus research. Its established renal glucose reabsorption mechanism should not be confused with mTOR inhibition, which was not detected in a drug-sensitized yeast growth model.

• Tyrothricin: Membrane-Disruption Research Workflows

  2026-08-15

  Tyrothricin is a peptide antibiotic mixture suited to mechanism-focused bacterial and fungal assays, from rapid membrane-permeability tests to orthogonal growth and viability workflows. This guide connects practical assay design with a lens oxidative-stress study, showing how dynamic sampling and perturbation controls can improve interpretation without overstating cross-domain evidence.

• Novel FLCN Mutations and mRNA Rescue in BHD

  2026-08-14

  A 2026 study identified the rare FLCN variants p.W376R and p.Q44* in two Chinese Birt-Hogg-Dubé families and combined genetic segregation with cellular functional testing. Exogenous FLCN mRNA restored protein expression and normalized mTORC1 signaling in HEK293T cells, providing an early proof of concept for mRNA-based replacement while remaining distant from clinical therapy.

• Demethyleneberberine: From Mechanism to Translation

  2026-08-14

  Demethyleneberberine (DMB) is a multi-pathway natural alkaloid with translational potential across inflammation, oncology, and neuroprotection. This thought-leadership guide connects mitochondrial immune regulation to practical model selection, formulation, and evidence-building strategies.

• Dovitinib: From RTK Signaling to Cardiac Assays

  2026-08-13

  Dovitinib (TKI-258) is a multitargeted RTK inhibitor whose pathway effects can be interpreted more rigorously in biologically defined models. This article connects its cancer-research utility with chamber-specific hPSC-cardiomyocyte assay design while clearly separating established evidence from exploratory applications.

• Candida EVs, Nrg1, and Candidemia Control

  2026-08-13

  The reference study identifies a concentration- and time-dependent role for Candida albicans extracellular vesicles (EVs): accumulated EVs suppress hyphal development by increasing the transcriptional repressor NRG1 through SKO1-associated regulation. Genetic and mouse infection experiments connect this pathway to reduced fungal virulence, while also defining important limits for translating EV biology into therapeutic strategies.

• MK-5108 (VX-689): Aurora-A Kinase Inhibition

  2026-08-12

  This scenario-based guide explains how MK-5108 (VX-689), supplied as SKU A4120, can improve the interpretation and reproducibility of Aurora-A-focused viability, proliferation, and cytotoxicity studies. It covers biochemical selectivity, DMSO formulation, assay controls, dose optimization, data interpretation, and practical vendor-selection criteria.

• Aurora A in Retinoblastoma: Evidence for Targeting

  2026-08-12

  This 2024 study identifies Aurora kinase A (AURKA) overexpression as a feature of human retinoblastoma associated with histopathologic high-risk factors and poor chemotherapy response. By combining patient-tissue analysis with genetic and pharmacologic perturbation across experimental models, the investigators provide a rationale for testing AURKA-directed strategies in advanced or refractory disease.

• AMG 487 for Reliable CXCR3 Assays

  2026-08-11

  AMG 487 (SKU B3266) is a selective CXCR3 antagonist for separating receptor-mediated migration, calcium signaling, and macrophage-state effects from nonspecific assay toxicity. This scenario-based guide covers solvent handling, dose selection, interpretation, and practical vendor evaluation using product data and a recent CXCL10–CXCR3 study.

• Ferritin Hybrid Particles for Combination Vaccines

  2026-08-11

  The reference study develops an Escherichia coli-produced ferritin hybrid particle displaying influenza A M2e and SARS-CoV-2 S-protein tandem epitopes in one assembled vaccine platform. In mice, the hybrid particle generated stronger antigen-specific responses than antigen-only or homologous ferritin constructs and produced sera with functional antiviral, binding, and ADCC-related activity.

• HotStart 2X Green qPCR Master Mix for STING Pathway Studies

  2026-08-10

  Build a reproducible SYBR Green workflow for profiling STING, p38 MAPK, inflammatory, and fibrotic transcripts after glaucoma filtration surgery. This practical guide combines assay design, hot-start specificity, RNA-seq validation, and troubleshooting with executable qPCR starting conditions.

• Streptavidin-Cy3 for NPC Metastasis Workflows

  2026-08-09

  Learn how to use Streptavidin-Cy3 as a bright biotin detection reagent across immunohistochemistry, immunofluorescence, in situ hybridization, and flow cytometry. The workflow connects practical fluorescent readouts with the super-enhancer RNA and NPM1/c-Myc/NDRG1 findings reported in nasopharyngeal carcinoma research.

• Cy5.5 NHS Ester for NIR Biomolecule Imaging

  2026-08-08

  Cy5.5 NHS ester enables covalent near-infrared labeling of proteins, peptides, and amine-modified nucleic acids for sensitive analytical and in vivo imaging workflows. This guide combines practical conjugation parameters with a translational use case: tracking mushroom polysaccharide distribution without confusing fluorescent labeling with biological activity.

• Cy5 RNA Labeling Kit: From LLPS to Probe Design

  2026-08-07

  The Cy5 RNA labeling kit K1062 connects controllable fluorescent nucleotide incorporation with mechanistic studies of RNA–protein condensation. Learn how to translate SARS-CoV-2 nucleocapsid phase-separation findings into better probe design, controls, and imaging workflows.

• Cucurbitacin I (JSI-124): Advanced STAT3 Inhibition in Cance

  2026-08-07

  Cucurbitacin I (JSI-124) stands out for its highly selective STAT3 pathway inhibition, enabling researchers to dissect tumor proliferation and survival with precision tools. This guide delivers optimized protocols, troubleshooting advice, and cross-study insights for maximizing the compound’s impact in cancer and neuro-cardiac research models.

7789 records 4/520 page Previous Next 12345 下5页 Last page